You are viewing a limited version of this profile. To access i3's full capabilities.
Verenium
Save
Company logo (jpg or png)
Parent company

Short description

Developer and commercializer of high-performance enzymes for use in industrial processes

Founded in 2007
Founded in

Company type Acquired Public (VRNM)
Company type

Industry Group materials & chemicals

Sector fuels & chemicals

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters San Diego, CA San Diego, United States
Address
City
State
Zip
Country

Parent Companies

Updated by Cleantech Group on 03/12/2020

Traction
  • 1 M&A items
tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
01/30/2012
Tate & Lyle Tate & Lyle
Tate & Lyle will use one of Verenium's proprietary enzyme products in the development of novel food ingredients.
View source    
Confirmed by Tate & Lyle
Licensee
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

VRNM

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
12/10/2012 Athyrium Capital Management Athyrium Capital Management (1)
Post-money valuation of
This secured debt financing round, which was accompanied by an issue of warrants to Athyrium to purchase approximately 2.9 million shares at $2.49 per share (a 17.5% premium), will provide Verenium with funds to advance its product pipeline to commercialization, enhance its manufacturing capabilities, and for general working capital.
Structured Debt $22,500,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font